Paediatric Consumer Health in Japan

Paediatric Consumer Health in Japan

Paediatric consumer health in Japan is set to see insignificant retail current value growth in 2024, remaining almost flat overall. Looking at the different categories, paediatric analgesics and paediatric cough, cold and allergy remedies are expected to see above-average performances, benefiting from the sustained high incidence of various infectious diseases in 2024, such as COVID-19, colds, and flu, similar to adult products.

Euromonitor International's Paediatric Consumer Health in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.